Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| OTC Markets | USD | Delayed | ||
| OTC Markets | USD | Delayed | ||
| BATS Europe | CHF | Delayed | ||
| BATS Europe | CHF | Delayed | ||
| London | CHF | Real-time | ||
| London | CHF | Real-time | ||
| Mexico | MXN | Delayed | ||
| Switzerland | CHF | Delayed | ||
| Switzerland | CHF | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed |
Roche Holding AG (OTC: RHHBY) raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, driven by demand for COVID-19 tests and the strong performance in the...
Here's a roundup of top ...Full story available on Benzinga.com
Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusEntasis Announces Positive Data For Late-Stage Study Of SUL-DUR In Acinetobacter...
The WisdomTree International Equity ETF (DWM) made its debut on 06/16/2006, and is a smart beta exchange traded fund that provides broad exposure to the Broad Developed World ETFs...
Europe is home to some of the largest companies in the world, with market capitalizations in the hundreds of billions of dollars. However, these large European companies are not...
Roche RHHBY (OTC:RHHBY) recently announced that the FDA has approved immuno-oncology drug Tecentriq (atezolizumab) for another indication.Tecentriq is now approved as adjuvant...
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women’s health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. The company has collaboration with Gilead Sciences, Inc. for COVID-19; a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza, as well as SemaThera Inc. to develop biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases; and has collaboration with Affimed N.V to study AFM24 in combination with PD-L1 checkpoint inhibitor in EGFR expressing solid tumors, as well as with Surface Oncology, Inc. to evaluate SRF388. It also has a clinical collaboration with Carrick Therapeutics, Ltd. to evaluate a novel combination of Carrick’s samuraciclib and its giredestrant in CDK4/6i resistant HR+, HER2- metastatic breast cancer; a collaboration with Zur Rose Group AG to empower people with diabetes and their caregivers in their daily therapy management; and a research collaboration and license agreement with Venatorx Pharmaceuticals, Inc. to discover, characterize, and develop new small molecule inhibitors of the Penicillin Binding Proteins in Gram-negative bacteria focused on agents active against carbapenem-resistant Enterobacterales. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Sell | Strong Buy |
| Technical Indicators | Strong Sell | Sell | Strong Buy | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Neutral | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 156.81 | 160.45 | 156.36 | -5.13 | -3.17% | 76.09M | NASDAQ | |||
| 2,843.70 | 2,891.10 | 2,836.90 | -78.7 | -2.69% | 1.52M | NASDAQ | |||
| 333.12 | 337.75 | 331.90 | -7.94 | -2.33% | 14.69M | NASDAQ | |||
| 45.90 | 46.15 | 45.29 | -0.72 | -1.54% | 4.29M | NASDAQ | |||
| 51.80 | 52.20 | 51.10 | +0.14 | +0.27% | 17.04M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 48.78 | 49.17 | 48.12 | -0.98 | -1.97% | 25.26M | NASDAQ | |||
| 54.00 | 54.94 | 53.25 | +3.11 | +6.11% | 66.54M | NYSE | |||
| 133.35 | 133.98 | 131.22 | -3.17 | -2.32% | 14.80M | NYSE | |||
| 54.67 | 55.19 | 54.46 | -0.87 | -1.57% | 16.73M | NASDAQ | |||
| 3,504.56 | 3,633.50 | 3,504.15 | -75.85 | -2.12% | 2.99M | NASDAQ | |||
| 24.77 | 25.12 | 24.20 | -1.87 | -7.02% | 10.30M | NYSE | |||
| 114.51 | 114.83 | 112.63 | -2.68 | -2.29% | 11.36M | NYSE | |||
| 6.13 | 6.30 | 6.00 | -0.100 | -1.61% | 11.67M | NYSE | |||
| 315.03 | 327.10 | 313.50 | -11.71 | -3.58% | 27.54M | NASDAQ |